Fri.Dec 13, 2024

article thumbnail

Opinion: I have a rare form of ALS. I have to fight my insurance company every six months for a game-changing drug

STAT

When I was diagnosed at age 22 with ALS, a fatal disease without a cure, I knew I was going to have to fight for my life. I just didn’t know I would also have to fight against insurance companies denying me access to life-extending treatments. Amyotrophic lateral sclerosis, or ALS, takes your ability to walk, talk, eat, and eventually breathe.

267
267
article thumbnail

Will the ‘anti-woke’ movement derail DEI efforts in pharma?

PharmaVoice

Amid the DEI backlash in corporate America, pharma leaders are quietly adjusting tactics.

246
246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

HHMI’s move to diversify funding sparks debate about ‘biomedical elite’

STAT

One of the world’s largest funders of biomedical research is looking to spread the wealth around a little more evenly. The nonprofit Howard Hughes Medical Institute (HHMI) will bar institutions that already have two or more beneficiaries of its Investigator Program from applying for a round of funds to be awarded in 2027. The goal is to “broaden institutional representation by encouraging applications from scientists in geographic regions where HHMI is not currently supporting scie

263
263
article thumbnail

SAEM Clinical Images Series: My Mom Could Not See

ALiEM - Pharm Pearls

An 87-year-old female with a history of hypertension, hyperlipidemia, chronic kidney disease stage IIIB, type 2 diabetes mellitus, and schizophrenia presented for evaluation due to sudden visual loss in her right eye, which began 12 hours before she arrived at the emergency department. She has experienced a sudden loss of vision in her right eye for more than six hours.

Diabetes 130
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Opinion: Inclusive immigration policies protect America’s health care

STAT

When I left Syria in 2014, I had a dream of becoming a U.S.-trained physician. I quickly realized that the American dream is real and that hard work truly pays off. I completed my master’s degree in international health policy and management, along with my clinical training in both internal and vascular medicine, at highly reputable institutions.

259
259

More Trending

article thumbnail

STAT+: South African regulator decides Vertex provides sufficient access to CF drugs, angering activists

STAT

After a lengthy investigation, South African regulators decided Vertex Pharmaceuticals has sufficiently provided access to its cystic fibrosis medications, ending a high-profile episode that placed the company on the defensive over the cost of its treatments. But the move angered patient activists who argued the arrangement is inequitable and that some patients “will continue to suffer and die.

article thumbnail

Pharmaceutical data and analytics market to grow to $2.1 bn by 2028: GlobalData

Express Pharma

The global data and analytics market in the pharmaceutical sector was valued at $1.1 billion in 2022 and is forecast to grow to $2.1 billion by 2028, driven by data and content management, according to GlobalData. According to GlobalDatas latest report, Market and Opportunity Forecast to 2028, Data and Analytics 2024, the total global data and analytics market is forecast to increase at a compound annual growth rate (CAGR) of 9.5 per cent from $101 billion in 2022 to $190 billion by 2028.

article thumbnail

STAT+: Report: Tuberculosis R&D funding is up, but still short of goals and dominated by a few players

STAT

Although research and development funding for tuberculosis reached new heights last year, the total fell substantially short of goals set by the United Nations and most of the increase came from just two organizations, according to a new report. Specifically, the amount spent on basic research, new treatments, vaccines, and diagnostics was $1.2 billion, the highest level since tracking of funding began in 2005 and 20% more than what was seen in 2022.

article thumbnail

Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance

Pharmafile

13 December 2024 Amsterdam, the Netherlands CPHI Milan the worlds largest pharma event hosted last month in Milan saw a new record attendance of 59,000 pharma executives buoyed by returning confidence and increased dealmaking on site. The events success is widely used as a proxy for overall growth in global pharma […] The post Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance appeared first on Pharmafile.

103
103
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: For a leukemia that keeps returning, AbbVie drug may offer chance for a deep remission

STAT

SAN DIEGO — Brian Koffman found himself in a situation a couple years ago that most chronic lymphocytic leukemia patients eventually do: relapse. The expectation in CLL is that, no matter what therapy or how many therapies patients have been on, the cancer will eventually recur if the patient lives long enough. The hope is that by that time, there will be yet another treatment to try.

article thumbnail

AIM ImmunoTech gains Netherlands patent for post-Covid fatigue therapy

Pharmaceutical Technology

AIM ImmunoTech has secured a patent from the Netherlands Patent Office for Ampligen, targeting the treatment of post-Covid fatigue.

98
article thumbnail

STAT+: Ionis blazed trails in genetic medicine. On the cusp of a major approval, can it also be a commercial success?

STAT

CARLSBAD, Calif. — Stroll inside Ionis Pharmaceuticals’ Southern California headquarters, past the giant hanging glass sculpture of an RNA molecule, and you can’t miss it on the back wall: In bright red, a digital countdown clock ticks off the days, hours, minutes, and seconds until a moment the biotech is betting will be transformational.

article thumbnail

Who Will Pay for Prescription Drugs in 2032: Four Takeaways from the New Government Forecasts (rerun)

Drug Channels

This week, Im rerunning some popular posts while I prepare for todays Drug Channels Outlook 2025 live video webinar. (If you sign up before 12 p.m. ET, you can attend the live event.) Click here to see the original post. The econowonks at the Centers for Medicare & Medicaid Services (CMS) recently released the latest projections for U.S. spending on healthcare.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

The conclusion(?) to the bird flu mystery and a Syrian doctor on coming to the U.S.

STAT

Happy birthday to Taylor Swift! She’s now old enough to run for president of the United States (not saying she SHOULD, just that she COULD…) And happy birthday to my feature from one year ago about a little girl named Shelby , whose one-time gene therapy miracle cure took place over a grueling year. (Don’t miss the Taylor Swift name drop in the piece itself!

229
229
article thumbnail

My 72-Hour Fast

The Honest Apothecary

Monday evening I was frustrated. Four weeks ago we had begun trying the carnivore diet. For me, it was an attempt to try something different to hopefully break out of a 6-month stall in my weight loss journey. Yes, that’s right. I began exercising and eating much better 1 year ago. Over the course of […] The post My 72-Hour Fast appeared first on The Honest Apothecary.

98
article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

229
229
article thumbnail

Dr Jitendra Singh chairs the 2nd Annual General Meeting of Biotechnology Research and Innovation Council Society

Express Pharma

The 2nd Annual General Meeting of the Biotechnology Research and Innovation Council (BRIC) Society was held under the Chairmanship of Union Minister of State (Independent Charge) for Science and Technology, Minister of State (Independent Charge) for Earth Sciences, MoS PMO, Department of Atomic Energy, Department of Space, Personnel, Public Grievances and Pensions, Dr Jitendra Singh, at the Department of Biotechnology (DBT), CGO Complex, New Delhi.

98
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

More reproductive health training needed for pharmacists, says report

The Pharmacist

More reproductive health training is needed for pharmacists and colleagues working in primary care settings, a new report has suggested. The Womens reproductive health conditions report, published this week by the Women and Equalities Committee, says primary care funding for training primary care staff currently prioritises long-term conditions like diabetes, above reproductive health.

article thumbnail

Innovative biologic prefilled syringe approved in EU

European Pharmaceutical Review

The European Medicines Agency (EMA) has approved Roche’s Vabysmo (faricimab) prefilled syringe (PFS) as the EUs first and only bispecific antibody prefilled syringe for retinal conditions causing vision loss. This authorises a novel CE-labelled needle for intravitreal injection. Vabysmo 6.0mg is indicated for treating neovascular or wet age-related macular degeneration (nAMD), diabetic macular oedema (DME) and macular oedema following retinal vein occlusion (RVO).

article thumbnail

Orpington PCN pharmacists named Pharmacy Team of the Year at GP Awards

The Pharmacist

The pharmacy team at Orpington PCN is celebrating a major win after being named Pharmacy Team of the Year at the Cogora General Practice Awards 2024. The award was collected by other members of the PCN on behalf of the pharmacy team last week, pictured above with with host John Robins, stand-up comedian, presenter and […] The post Orpington PCN pharmacists named Pharmacy Team of the Year at GP Awards appeared first on The Pharmacist.

98
article thumbnail

Five Lessons Learned About Antimicrobial Stewardship Metrics

ID Stewardship

In this article an experienced antimicrobial stewardship pharmacist discusses lessons learned from navigating antimicrobial stewardship metrics. Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article posted 13 December 2024 If you cannot measure it, you cannot determine if you have changedit. Antimicrobial stewardship metrics are essential for identifying, acting on, and re-evaluating opportunities to enhance the safe and appropriateuse of antibiotics.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

UKHSA reports hepatitis C decline among people who inject drugs

The Pharmacist

The rate of chronic hepatitis C infections for people who inject drugs has fallen in the last six years, according to the latest data from the UK Health Security Agency (UKHSA). A survey of people who inject drugs found 7.8% had hepatitis C, compared with 26% in 2017. Hepatitis C can be passed on through […] The post UKHSA reports hepatitis C decline among people who inject drugs appeared first on The Pharmacist.

article thumbnail

PulmCrit: ADAPT and SCREEN trials are full of sound and fury, signifying little

EMCrit Project

I think ICU docs may have developed a bit of an RCT problem; not an addiction, but perhaps a dependency. It all started off fine at first. RCTs are the apex trial design, the only trial capable of proving causality. But we've taken it too far. Currently, a cluster-randomized trial is underway to study whether […] EMCrit Project by Josh Farkas.

83
article thumbnail

‘Updated approach’ for quality checking pharmacy training and education

The Pharmacist

The pharmacy regulator has been given the green light to introduce enhanced processes to its quality assurance of pharmacists education and training. The General Pharmaceutical Council (GPhC) has been given approval by its governing council to carry out an annual survey of students and trainees about the quality of education and training they are receiving. […] The post Updated approach for quality checking pharmacy training and education appeared first on The Pharmacist.

80
article thumbnail

Breakthrough of the Year: A drug that prevents HIV infection, providing six months of protection per shot

World Pharma News

As its 2024 Breakthrough of The Year, Science has named the development of lenacapavir - a promising new injectable drug that prevents HIV infection. The award also recognizes related work surrounding gaining a new understanding of the structure and function of HIV's capsid protein. Despite decades of advancements, HIV continues to infect more than a million people annually, with a vaccine remaining elusive.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.